clofibrate has been researched along with Dermatitis, Atopic in 1 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukaya, M | 1 |
| Kimata, H | 1 |
1 trial available for clofibrate and Dermatitis, Atopic
| Article | Year |
|---|---|
Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study.
Topics: Administration, Cutaneous; Adult; Chemokine CCL17; Clofibrate; Dermatitis, Atopic; Dermatologic Agen | 2014 |